• PD 173074: Optimizing FGFR/VEGFR2 Inhibition in Cancer Resea

  2026-06-12

  PD 173074 stands out as a nanomolar-selective FGFR1/VEGFR2 inhibitor, empowering researchers to dissect tumor microenvironment signals and overcome resistance in cancer models. This guide brings experimental clarity—from precise protocol tweaks to troubleshooting—anchored in both recent literature and practical lab workflows.

• Alosetron: Precision 5-HT3 Receptor Antagonist for GI Resear

  2026-06-11

  Alosetron from APExBIO empowers gut biology researchers to dissect serotonin-driven pathways with unmatched selectivity and reproducibility. This article translates recent breakthroughs in epithelial polarity and stem cell fate into actionable protocols and troubleshooting strategies for advanced gastrointestinal models.

• Pseudo-UTP: Transforming mRNA Synthesis with Pseudo-Modified

  2026-06-11

  Pseudo-UTP empowers researchers to engineer highly stable, translation-efficient, and low-immunogenicity RNA, vital for cutting-edge mRNA vaccine development and gene therapy workflows. This guide distills experimental insights, troubleshooting strategies, and actionable protocol enhancements—bridging pioneering reference findings, peer best practices, and APExBIO's quality assurance.

• ARCA Cy3 EGFP mRNA (5-moUTP): Transforming mRNA Localization

  2026-06-10

  Explore how ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, advances quantitative mRNA delivery and localization studies in mammalian cells. This article provides an in-depth, evidence-based perspective on integrating this fluorescent mRNA into advanced assay design.

• CircRNA hsa_circ_0001944 Modulates FXR/TLR4-Ferroptosis Axis

  2026-06-10

  This study demonstrates that hsa_circ_0001944 regulates the FXR/TLR4 pathway and ferroptosis to alleviate collagen deposition caused by nickel oxide nanoparticles (NiONPs) in human hepatic stellate cells. By elucidating the molecular interplay between circRNA, nuclear receptor signaling, and ferroptosis, the findings provide new mechanistic insights into fibrogenesis and potential experimental avenues for antifibrotic research.

• Estradiol (SKU A8425): Optimizing Organ Protection Assays

  2026-06-09

  This article provides scenario-driven guidance for biomedical researchers and lab technicians using Estradiol (SKU A8425) to address common challenges in cell viability, proliferation, and cytotoxicity assays. It details evidence-backed workflows, vendor selection, and protocol optimizations, highlighting how Estradiol from APExBIO ensures reproducibility and data quality in estrogen receptor signaling research.

• RepSox (ALK5 Inhibitor): Redefining iPSC-Derived Platelet Ma

  2026-06-09

  Explore how RepSox, a potent ALK5 inhibitor, is transforming induced pluripotent stem cell reprogramming and ex vivo platelet production. This article delivers unique practical insights into protocol design, efficiency optimization, and the scientific rationale behind TGF-β pathway inhibition.

• Gingerenone A Targets LDHA to Overcome Sunitinib Resistance

  2026-06-08

  This study demonstrates that gingerenone A, a natural compound from ginger, inhibits LDHA-driven glycolysis in renal cell carcinoma (RCC), disrupting key metabolic and angiogenic pathways. By restoring sensitivity to sunitinib, gingerenone A provides a promising metabolic strategy for tackling drug-resistant RCC.

• Fe3O4@ZIF-8 Nanoparticles for Dual Antibiosis and Osteogenes

  2026-06-08

  This study introduces Fe3O4@ZIF-8 core–shell nanoparticles as a multifunctional platform for jaw osteomyelitis, combining pH-responsive antibacterial action with magnetic field-assisted bone regeneration. The findings advance translational strategies for simultaneously addressing persistent infection and bone defect repair in challenging clinical contexts.

• Crizotinib Hydrochloride in Tumor Microenvironment Research

  2026-06-07

  Explore the unique role of Crizotinib hydrochloride as an ALK kinase inhibitor in dissecting tumor–stroma interactions and resistance mechanisms using advanced assembloid models. This article provides deep technical insight for cancer biology research.

• Broad Neutralization by mRNA Vaccines Against SARS-CoV-2 Omi

  2026-06-06

  Wang et al. demonstrate that a prime-boost strategy using BA1 spike mRNA followed by two receptor-binding domain (RBD) mRNA boosts elicits potent neutralizing antibodies against a wide spectrum of SARS-CoV-2 variants, including highly evasive Omicron subvariants. These results inform rational design of next-generation mRNA vaccines and underscore the importance of optimized antigen selection and delivery.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-06-05

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers dual-fluorescence tracking and robust, immune-evasive expression for next-generation mRNA delivery research. Discover optimized protocols, troubleshooting strategies, and comparative advantages that set this Cy5-labeled mRNA apart for quantitative transfection, gene regulation, and nanoparticle validation workflows.

• CDC42-Driven Polarity Modulates Intestinal Stem Cell Fate vi

  2026-06-05

  The reference study uncovers how CDC42-mediated apical-basal polarity orchestrates the fate transition from intestinal stem cells to transit amplifying cells via a Hippo-YAP-EGF-mTOR cascade, independent of canonical Wnt signaling. These findings clarify the molecular architecture of epithelial homeostasis and provide refined targets for gastrointestinal stem cell research.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Advance

  2026-06-04

  1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) stands at the forefront of nucleic acid delivery, enabling precise gene expression and functional genomics in both basic and translational research. This guide translates the latest nanoformulation advances into actionable protocols, troubleshooting, and experimental design tips for maximizing DOTAP’s performance.

• CDC42 Polarity Regulates ISC Fate via YAP-EGF-mTOR Signaling

  2026-06-04

  Zhang et al. reveal that CDC42-controlled apical-basal polarity governs the transition of intestinal stem cells (ISCs) to transit amplifying (TA) cells through the YAP-EGF-mTOR pathway. Their findings redefine the centrality of epithelial polarity in intestinal homeostasis and open new avenues for dissecting stem cell fate mechanisms in gastrointestinal research.

673 records 15/45 page Previous Next First page 上5页 1112131415 下5页 Last page